By slowing gastric emptying and enhancing insulin sensitivity, GLP-1 receptor agonists have been clinically proven to promote steady, sustainable weight loss, all while supporting healthy blood sugar control
Independent labs routinely test compounded batches to confirm accuracy, purity, and compliance with USP guidelines
8 unique PW/CW modes allow for effective targeting of a variety of skin concerns including skin laxity, pigmentation issues, scarring, fine lines and wrinkles, and general tone and texture of the skin
Arch Opthalmol 2004;122:477-485
Is more testing necessary
The medication enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, delays gastric emptying, and reduces appetite through central mechanisms